Geneos Wealth Management’s T. Rowe Price Growth ETF TGRT Stock Holding History

Geneos Wealth Management’s Portfolio TGRT Stock Details TGRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$132K	Sell	2,886 -4,740	-62%	-$212K	﹤0.01%	1126
2026 Q1	$300K	Sell	7,626 -303	-4%	-$12.8K	0.01%	832
2025 Q4	$351K	Buy	7,929 +310	+4%	+$13.7K	0.01%	765
2025 Q3	$332K	Buy	7,619 +2,125	+39%	+$89K	0.01%	759
2025 Q2	$222K	Buy	5,494 +1,188	+28%	+$43.2K	0.01%	951
2025 Q1	$148K	Buy	4,306 +811	+23%	+$30.3K	﹤0.01%	1034
2024 Q4	$132K	Buy	+3,495	New	+$131K	﹤0.01%	975

Other funds holding TGRT

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIAS

Mason Investment Advisory Services Reston, Virginia $2.63B AUM 41.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

NWA

Northwest Wealth Advisors Bellingham, Washington $174M AUM

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Geneos Wealth Management's TGRT Position: Q2 2026 in Review

Geneos Wealth Management reduced its T. Rowe Price Growth ETF (TGRT) stake by 62% in Q2 2026, selling an estimated $212K and leaving 2,886 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

Geneos Wealth Management first reported a position in TGRT in Q4 2024 and has held it in 7 quarters since. The position peaked at $351K in Q4 2025. 50 funds tracked by Wall St. Rank hold TGRT as of Q2 2026.

Geneos Wealth Management held 2,886 shares of T. Rowe Price Growth ETF worth $132K as of Q2 2026.
Geneos Wealth Management sold 4,740 T. Rowe Price Growth ETF shares in Q2 2026, an estimated $212K.
T. Rowe Price Growth ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1126 holding.
Geneos Wealth Management first reported a position in T. Rowe Price Growth ETF in Q4 2024 and has held it in 7 quarters since.
Geneos Wealth Management's T. Rowe Price Growth ETF position peaked at $351K in Q4 2025.
50 funds tracked by Wall St. Rank held T. Rowe Price Growth ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.